Английская Википедия:DHA-clozapine

Материал из Онлайн справочника
Версия от 20:42, 23 февраля 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{short description|Chemical compound}} {{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 462084620 | IUPAC_name = (4''Z'',7''Z'',10''Z'',13''Z'',16''Z'',19''Z'')-1-[3-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzodiazepin-11-yl]docosa-4,7,10,13,16,19-hexaen-1-one | image = Docosahexaenoyl-clozapine.svg | alt = | caption = <!--Clinical data--> | tr...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

DHA-clozapine (tentative trade name Clozaprexin)[1] is an atypical antipsychotic drug candidate that was created and originally tested by chemists at Protarga, a small pharmaceutical in Pennsylvania, and scientists at Harvard University.[2]

It is a prodrug of clozapine; the fatty acid docosahexaenoic acid (DHA) was added to clozapine in order to increase penetration of the blood–brain barrier.[3]

Protarga was purchased by Luitpold Pharmaceuticals in 2003 and development was discontinued in 2007.[1]


References

Шаблон:Reflist

Шаблон:Antipsychotics Шаблон:Adrenergics Шаблон:Cholinergics Шаблон:Dopaminergics Шаблон:Histaminergics Шаблон:Serotonergics Шаблон:Piperazines Шаблон:Tricyclics

Шаблон:Nervous-system-drug-stub